S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
NYSEARCA:REVS

Columbia Research Enhanced Value ETF Stock Forecast, Price & News

$20.86
+0.14 (+0.68 %)
(As of 10/15/2021 12:00 AM ET)
Add
Today's Range
$20.83
$20.93
50-Day Range
$20.09
$21.06
52-Week Range
$16.45
$21.46
Volume3,900 shs
Average Volume6,007 shs
Market Capitalization$10.95 million
P/E RatioN/A
Dividend Yield22.52%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive REVS News and Ratings via Email

Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Columbia
Fund NameColumbia Research Enhanced Value ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:REVS
Inception Date9/25/2019
Fund ManagerChristopher Lo, Jason Wang
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkBeta Advantage Research Enhanced U.S. Value Index
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$10.93 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.19%
Other Expenses0.00%
Total Expenses0.19%
Fee Waiver0.00%
Net Expenses0.19%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorColumbia Management Investment Advisers, LLC
CustodianThe Bank of New York Mellon Corporation
DistributorALPS Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market Maker

Geographic Exposure of REVS

Currency Exposure of REVS

Sector Exposure of REVS

Industry Exposure of REVS













Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Frequently Asked Questions

What stocks does MarketBeat like better than Columbia Research Enhanced Value ETF?

Wall Street analysts have given Columbia Research Enhanced Value ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Columbia Research Enhanced Value ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Columbia Research Enhanced Value ETF's stock price been impacted by COVID-19?

Columbia Research Enhanced Value ETF's stock was trading at $17.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, REVS shares have increased by 22.1% and is now trading at $20.86.
View which stocks have been most impacted by COVID-19
.

Is Columbia Research Enhanced Value ETF a good dividend stock?

Columbia Research Enhanced Value ETF pays an annual dividend of $4.67 per share and currently has a dividend yield of 22.52%. REVS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Columbia Research Enhanced Value ETF's dividend history.

What is Columbia Research Enhanced Value ETF's stock symbol?

Columbia Research Enhanced Value ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "REVS."

How do I buy shares of Columbia Research Enhanced Value ETF?

Shares of REVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Columbia Research Enhanced Value ETF's stock price today?

One share of REVS stock can currently be purchased for approximately $20.86.

How much money does Columbia Research Enhanced Value ETF make?

Columbia Research Enhanced Value ETF has a market capitalization of $10.95 million.


This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.